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The documented increase in asthma prevalence
over the last 25 years (Mannino et al. 2002) is
likely due to changes in our environment or
lifestyle because changes in our genetic makeup
would take more than several generations to
occur. When investigating environmental expo-
sures [e.g., outdoor, environmental tobacco
smoke, pollen, viruses (Gilmour et al. 2006;
Zeldin et al. 2006)] in relation to asthma inci-
dence and induction, we need to consider
“susceptibility” factors in order to ascertain
the relative contribution of an environmental
effect and potential interactions. In this arti-
cle, we deﬁne “susceptibility factors” broadly
to include populations at risk (e.g., the very
young, elderly, or genetically at risk), known
risk factors, and known protective factors
(“farm” exposure in utero or in infancy).
From an epidemiologic framework, we have
included variables that are sometimes consid-
ered confounders or effect modiﬁers, such as
smoking or obesity (Figure 1).
Most epidemiologic research on asthma
and environmental risk factors has focused on
prevalence because prevalent asthma is easier to
measure than incident asthma. Prevalence (P)
is the product of the incidence (I) of the disease
times the duration (D): P = I × D. Compared
with prevalence, much less is known about
factors associated with incident asthma. Thus,
we include in this article factors associated
with prevalent asthma, acknowledging that
factors that influence the prevalence of the
disease may not necessarily affect the inci-
dence of the disease in the same way and that
additional factors may affect the remission of
the disease.
The following “susceptibility factors,” dis-
cussed at the U.S. Environmental Protection
Agency (EPA) workshop “Environmental
Inﬂuences on the Induction and Incidence of
Asthma” held 19–20 October 2004, are con-
sidered in this article by experts in their ﬁelds:
genetics, “window of exposure” (age: fetus,
infant, childhood, adult, elderly), occupational
asthma (OA), and lifestyle factors (diet, obe-
sity). We deﬁne susceptibility as the degree to
which a person or a population is sensitive to
either adverse or protective exposures in devel-
oping asthma (U.S. EPA 2002). Smoking is
also brieﬂy mentioned here but is addressed in
more detail in Gilmour et al. (2006). We also
include a brief discussion of expanding the
hygiene hypothesis. For population-level con-
textual analyses of susceptibility factors, dispar-
ities, and asthma, see Gold and Wright (2005),
and for a thorough review of cohort studies on
asthma incidence, see King et al. (2004).
Genetics of Asthma and
Gene–Environment Interactions
Studies of family history and genetic studies of
familial aggregation and segregation of asthma
have convincingly shown that the disease has a
strong genetic component. Many investigators
have sought to identify the speciﬁc genes and
polymorphisms that determine hereditary sus-
ceptibility to the disease (Colhoun et al. 2003;
Cookson 2004; Cookson and Moffatt 2004).
A recent review of the literature identified
more than 100 reports of genetic variants
associated with asthma and asthma-related
traits (Hoffjan et al. 2003). Among the more
striking conclusions that can be reached from
that review is that initial descriptions of
“asthma” genes, identified both by linkage
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Relative to research on effects of environmental exposures on exacerbation of existing asthma, little
research on incident asthma and environmental exposures has been conducted. However, this
research is needed to better devise strategies for the prevention of asthma. The U.S. Environmental
Protection Agency (EPA) and National Institute of Environmental Health Sciences held a confer-
ence in October 2004 to collaboratively discuss a future research agenda in this area. The ﬁrst three
articles in this mini-monograph summarize the discussion on potential putative environmental
exposure; they include an overview of asthma and conclusions of the workshop participants with
respect to public health actions that could currently be applied to the problem and research needs
to better understand and control the induction and incidence of asthma, the potential role of
indoor/outdoor air pollutants in the induction of asthma), and biologics in the induction of
asthma. Susceptibility is a key concept in the U.S. EPA “Asthma Research Strategy” document and
is associated with the U.S. EPA framework of protecting vulnerable populations from potentially
harmful environmental exposures. Genetics, age, and lifestyle (obesity, diet) are major susceptibility
factors in the induction of asthma and can interact with environmental exposures either syner-
gistically or antagonistically. Therefore, in this fourth and last article we consider a number of “sus-
ceptibility factors” that potentially influence the asthmatic response to environmental exposures
and propose a framework for developing research hypotheses regarding the effects of environmental
exposures on asthma incidence and induction. Key words: asthma, epidemiology, genetics, hygiene
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replicate. No more than 8–10 such genes have
been replicated in three or more studies, and
none of these genes have been consistently
associated with the same asthma phenotype in
studies to date (Hoffjan et al. 2003).
Various technical reasons may explain these
disappointing results. Type I and type II errors,
for example, can result in spurious results or in
results that cannot be replicated (Rothman and
Greenland 1998) Similarily, publication bias
(i.e., the underreporting of negative results)
results in an exaggeration of the true statistical
signiﬁcance of any positive results (Rothman
and Greenland 1998). Additionally, many
replication studies either lack sufﬁcient power
or fail to define the phenotypes in ways that
match the deﬁnitions used in the original work.
Although most of the literature on these
issues has acknowledged these technical prob-
lems, analyses of the published results of popu-
lation studies suggest that the discrepancies
among results cannot be attributed only to
deﬁciencies in study design or in the statistical
analysis of the data. It is now clear that asthma
is a heterogeneous condition (Douwes et al.
2002; Martinez 2002), that different forms of
asthma may predominate in different geo-
graphic locations (e.g., the inner city or rural
area), and that induction of asthma is strongly
inﬂuenced by environmental factors that may
differ among populations and at different ages
(Eder et al. 2004, 2005). Moreover, different
environmental exposures that increase or
decrease the likelihood of developing asthma
interact with different clusters of genetic varia-
tions. Almost paradoxically, then, a signiﬁcant
part of the genetic determination of asthma
depends upon the environmental factors that
trigger the disease (Patino and Martinez 2001).
Recently, for example, researchers in
Germany, Austria, and Switzerland have
shown that, in rural areas of those countries,
children raised in the farm animal environ-
ment are much less likely to have asthma and
allergic sensitization than are those raised in the
same rural areas but away from such farms
(Braunfahrlander et al. 2002). Furthermore,
polymorphisms in the toll-like receptor 2 gene
(TLR2; GenBank accession no. U88878;
http://www.ncbi.nlm.gov) appear to modulate
the protective effect of the farm environment:
only carriers of certain TLR2 polymorphisms
are protected by this environment (Eder et al.
2004). Because TLR2 is a receptor for microbial
products (mainly gram-positive bacteria) that
are known to be present in the farm animal
environment, it is suspected (but not yet
demonstrated) that these polymorphisms in
TLR2 may increase or decrease the reactivity of
the individual to these products. Note that toll-
like receptor 4 (TLR4; GenBank accession no.
U88880; http://www.ncbi.nlm.gov) is the prin-
cipal receptor for bacterial endotoxin, a glycol-
ipid of the outer cell wall of gram-negative
bacteria, whereas TLR2 is part of the signaling
complex responding to cell membranes of
gram-positive and -negative bacteria, myco-
plasma, mycobacteria, parasites, and yeast
(Eder et al. 2004; Lien et al. 1999). Similar
gene–environment interactions have been
described (Eder et al. 2005) for the potential
association between allergic phenotypes and a
polymorphism in the promoter region of the
CD14 gene (GenBank accession no. X06882;
http://www.ncbi.nlm.gov). This gene encodes a
receptor required for activation of TLR4 by
endotoxin. Thus, the identity of polymorphic
genes modulating development of allergic sensi-
tization may vary depending on speciﬁc envi-
ronmental exposures. These findings further
suggest that the development of specific
T helper (TH) 2-type immunity (allergy) is
strongly inﬂuenced by the state of activation of
the innate immune system, the maturation state
of the developing innate immune system at the
time of microbial exposure, and the responsive-
ness of the latter to ligands that are generally
derived from exogenous microbial products but
may include endogenous compounds.
Genetic polymorphisms that inﬂuence sus-
ceptibility to the development of asthma exist,
regardless of the environment in which the
individual is raised or lives, and similarly, envi-
ronmental exposures, may inﬂuence to some
degree the susceptibility to allergic airways dis-
ease in the absence of genetic predisposition
(Eder et al. 2005). However, it is likely that the
risk of developing asthma is greatest when both
genetic and environmental risk factors are
present simultaneously. Evidence to date sug-
gests that asthma induction is the result of com-
plex interactions between speciﬁc exposures and
the genes that interact with such exposures dur-
ing crucial periods in the natural history of 
the disease. The current “epidemic” of asthma
cannot be explained by genetic factors, but
genetic factors may still be important with
regard to susceptibility issues.
Windows of Exposure
Inﬂuence of in utero and postnatal events. The
in utero environment is the ﬁrst environment
to which an individual is exposed. Exposures
in utero occurring during the critical periods
for organogenesis have the potential to produce
long-lasting effects. Postnatal organ function
can be profoundly affected by in utero expo-
sures (Stick et al. 1996), and the “fetal origins
of adult disease” have attracted considerable
research attention recently. Postnatal respira-
tory function is largely determined by lung
development in utero, with strong tracking of
respiratory function throughout childhood
(Hibbert et al. 1990). Specifically, children
born with low lung function are likely to have
low lung function throughout childhood and
into adult life.
A number of other factors must also be
considered when assessing the effects of
in utero exposures on the risk of developing
asthma (Table 1). Also important are timing of
T-cell memory programming, genetic pre-
dispositions for allergy and infections, and syn-
ergy of early respiratory infection and atopy.
Children born to atopic parents are at
increased risk of developing allergic sensitiza-
tion to common aeroallergens and asthma
(Holt et al. 1999). The child’s adaptive
immune system is functionally immature at
birth and undergoes slow postnatal maturation
(Yabuhara et al. 1997). Although genetic fac-
tors may inﬂuence immunologic development,
environmental inﬂuences are also possible. For
example, cord blood IgE levels are highest in
ﬁrst-born infants, and the in vitro proliferation
response of cord blood mononuclear cell
(CBMC) to mitogenic stimuli decreases with
birth order. A plausible explanation for this
phenomenon is an increasing response of the
maternal immune system to “paternal” human
leukocyte antigens in fetal cells. Such a
response is likely to be of the TH1 type and is
likely to counterbalance the TH2 skewed fetal
and neonatal responses. Pregnancy complica-
tions (McKeevar et al. 2002; Stazi et al. 2002)
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Table 1. Summary of possible antenatal inﬂuences
on the development of asthma and allergy.
Allergy Asthma
Birth order + +
Maternal allergen exposure +/– –
Maternal smoking during pregnancy +/– ++
Obstetric complications + +
Elective cesarean section – +
Maternal use of antibiotics during +/– +/–
pregnancy
Maternal diet, PUFA, antioxidants +/– +/–
Abbreviations: PUFA, polyunsaturated fatty acids; +, positive
association with disease outcome; –, negative association
with the disease outcome; +/–, equivocal data. Figure 1. Conceptual framework for susceptibility factors.
Indoor/outdoor air
Biologics
Endotoxin
Pets
Allergens
Environmental
Exposures
Susceptibility
Factors
Genetics
“Window of exposure”
  (age)
Obesity
Smoking
Diet
Breast-feeding
Lung growth
Outcomes
Atopic asthma
Nonatopic asthma
Atopy
Remissionand delivery by cesarean section are risk factors
for asthma and allergies (Negele et al. 2004).
There is a synergistic interaction between
infections in early life and development of
atopy and subsequent asthma by 6 years of age
(Oddy et al. 1999).
The fetal and maternal placental tissues
secrete a variety of cytokines, including “acute-
phase” cytokines [interleukin (IL)-6, IL-10]
and “anti-TH1” cytokines [IL-4, IL-10, IL-13,
tumor growth factor 2 (TGF2)]. In addition
to being essential for continued pregnancy,
these cytokines may inﬂuence the developing
fetal immune system and be responsible for
the TH2 bias seen in stimulated CBMCs
in vitro. Infants born to smoking mothers have
lower levels of cytokines (both TH1 and TH2)
in their cord blood, demonstrating that pla-
cental trophoblasts are vulnerable to in utero
exposures (Macaubas et al. 2003), which
could result in immune dysregulation.
The question of whether fetal priming to
environmental allergens occurs in utero is
controversial. It is not certain whether aller-
gens cross the placenta in vivo; although this
has been demonstrated using perfused placen-
tal models in vitro, the relevance of these ﬁnd-
ings is unclear. The results of strict dietary
allergen-avoidance strategies during preg-
nancy (intended to decrease the severity of
allergy and asthma in the offspring) have been
disappointing and may even increase the
severity of clinical atopy when exposure occurs
postnatally (Kramer and Kakuma 2003).
CBMC responses to aeroallergens have been
demonstrated using in vitro stimulation proto-
cols. However, several lines of evidence suggest
that these responses should not be taken as
evidence for in utero priming to allergens
(Thornton et al. 2004). This evidence includes
the lack of both a qualitative and a quantita-
tive difference in responses from CBMC
obtained from high-risk and low-risk infants
(Prescott et al. 1998, 1999) and the fact that
CBMC responses to seasonal allergens are not
restricted to mothers exposed to the allergen
during pregnancy.
The influence of maternal diet on infant
atopy outcomes is unclear. Maternal diets high
in linoleic acid have been associated with
increased cord blood IgE levels and increased
asthma. Fish oil supplementation has been
associated with lower CBMC cytokine
responses to in vitro stimulation in one study
(Dunstan 2003). Maternal diets high in
antioxidants have been associated with
decreased CBMC proliferative responses,
which may not necessarily indicate a beneﬁcial
effect, but also with decreased wheeze and
atopic dermatitis during infancy. The data on
the effects of fetal nutrition (both over- and
undernutrition) are contradictory, both
between and within studies (Katz et al. 2003;
Kramer and Kakuma 2003).
Maternal smoking during pregnancy is a
major in utero exposure that is associated with
poor fetal and infant outcome and increased
wheezing and asthma in children (Stick et al.
1996). The risk of developing asthma among
children 7 years of age increased in a dose-
dependent pattern with the mother’s smoking
rate in pregnancy: odds ratios were 1.25 (95%
conﬁdence interval (CI), 1.09–1.44) for < 10
cigarettes/day and 1.36 (1.14–1.63) for > 10
cigarettes/day (Jaakkola and Gissler 2004) in
a Finnish birth cohort that included almost
60,000 children. Signiﬁcant associations per-
sisted even after adjustment for low birth
weight and duration of pregnancy, suggesting
that the effect of passive smoking on asthma
was independent of these factors.
The major harmful components of cigarette
smoke are nicotine and carbon monoxide
(Longo 1977; Sekhon et al. 2001). The physio-
logic consequences of exposure include con-
striction of uteroplacental circulation, increased
release of catecholamines, and decreased fetal
breathing movements. The adverse outcomes
include decreased birth weight, decreased cord
blood cytokines levels (both TH1 and TH2),
increased collagen deposition in airway and
alveolar walls, abnormal lung function at
birth, and suppressed ventilatory responses to
postnatal hypoxia (Sekhon et al. 2002; Ueda
et al. 1999). Prenatal alcohol and nicotine
exposure have additive effects on suppressing
peripheral blood mononuclear cells prolifera-
tive responses in the early postnatal months
(Basta et al. 2000).
In summary, in utero exposures can play
an important role in the development of atopy
and asthma. Maternal smoking is a major pre-
ventable risk factor for asthma, and fetal nutri-
tion and the influence of maternal diet
(notably antioxidants and omega-3 fatty acids)
are also important. The data on the effects of
other environmental agents are still equivocal.
CBMC studies need to be interpreted cau-
tiously, and evidence for in utero priming
remains dubious. Table 1 summarizes these
and other environmental factors.
Childhood. The following paragraphs
include descriptions of prevalent rather than
incident asthma because little is known about
incident childhood asthma. Asthma is the
most common chronic childhood disease
(Yunginger et al. 1992). In addition, there is
substantial wheezing in the general population
in early life such that 40% of all children have
a sustained wheezing illness in the ﬁrst year of
life and 20% are wheezing at 3 years of age,
with a similar percentage at 6 years of age
(Martinez et al. 1995). Considering observa-
tions that the mean duration of symptoms in
childhood is 2 years, it is clear that recall bias
for early-life symptoms is considerable (Sears
et al. 2003). Thus, recrudescence of symptoms
is common, and it is difficult, in adults, to
determine if the disease is truly incident or if it
is the reoccurrence of symptoms in a geneti-
cally susceptible individual.
Estimates of the effects of recall bias can
be made from prospective epidemiologic
studies. From 30 to 50% of children will for-
get that they had the diagnosis of asthma or
wheeze symptoms 3 years earlier (Sears et al.
2003). A major challenge is that we are still
unable to predict who will have their wheeze
symptoms persist and who will remit, based
on their presentation in early life.
There are several factors that are predictive
of asthma in childhood. Parental history is an
index of genetic susceptibility to asthma: 80%
of children with two asthmatic parents
develop the disease compared with 40% of
children with one asthmatic parent and 10%
of children with no asthmatic parents (Sibbald
et al. 1980). Sex is also a powerful predictor.
Males develop the disease 2 to 4 times more
frequently than females in the ﬁrst 3 years of
life, but females are more likely to have the
disease persist, especially if they have it after
puberty (Yunginger et al. 1992). This results
in equal prevalence of the disease by sex after
10 years of age, but females are more likely to
die and/or be hospitalized than males after this
age. Other predictors include the degree of air-
way reactivity and the presence of other atopic
diseases such as atopic dermatitis, allergic
rhinitis, food allergy, and urticaria. The more
severe the symptoms, the more likely the
disease will persist.
Young adulthood. Relatively little is known
about the important predictors of asthma in
young adulthood. Recently Wang et al. (2004)
reported on the importance of symptoms, air-
way responsiveness, eosinophilia, and smoking
as factors reducing maximally attained levels of
lung function in this age group. Smoking
interacts with airway responsiveness and is
associated with a higher likelihood of new
onset (or recrudescent) asthma in adulthood.
Asthmatics with more severe disease are more
likely to have been smokers.
Working-adult occupational asthma.
Work place exposures are responsible for
15–25% of asthma in adults (Arif et al. 2003a,
2003b; Balmes et al. 2003; Blanc et al. 2003;
Karjalainen et al. 2001). Hence, most informa-
tion on factors affecting adult onset asthma
comes from occupational studies. New-onset
work-related asthma can be subcategorized
into OA and irritant-induced asthma. OA
specifically refers to asthma that occurs as a
consequence of sensitization to causative agents
in the workplace, usually after an exposure his-
tory of months to years (Meijer et al. 2004).
Sensitizing agents that cause OA can be
divided into high-molecular-weight (HMW)
and low-molecular-weight (LMW) agents
(Chan-Yeung et al. 2003). In cross-sectional
studies, atopy has been a well-documented risk
Yeatts et al.
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HMW allergens. At least one cohort study sug-
gests that atopic phenotype can also be an out-
come of exposure to HMW occupational
allergen (Nguyen et al. 2003). In general,
HMW (≥ 5 kDa) agents are proteins and cause
OA via IgE sensitization. In contrast, LMW
(< 5 kDa) agents are considered too small to
induce immune sensitization by themselves.
They are thought to act as haptens, binding to
carrier proteins to form complete antigens with
the ability to induce immune responses.
Although some LMW agents such as platinum
clearly induce OA via IgE sensitization, this is
less clear for others such as isocyanates and pli-
catic acid (Weissman and Lewis 2000).
Effector mechanisms other than those medi-
ated by IgE, such as T-cell responses, probably
have important etiologic roles in OA induced
by these agents, and atopy is not a risk factor.
OA has been successfully prevented in sev-
eral settings (Cullinan et al. 2003). An impres-
sive example was elimination of asthma
outbreaks in the enzyme detergent industry in
the late 1960s and early 1970s (Cathcart et al.
1997; Schweigert et al. 2000). A more recent
example has been marked reduction in OA
caused by powdered natural rubber latex gloves
in the health care industry (Allmers et al. 2002;
Liss and Tarlo 2001). Guidelines have recently
been provided by the American Thoracic
Society (2004) on managing asthma risk at
work, school, and recreation that are applicable
to a range of asthma-inducing agents.
However, cohort studies that objectively
assess exposure–response relationships for
causative agents are available for only a minor-
ity of agents. Furthermore, studies have gener-
ally focused on inhalation exposure and have
not attempted to address the roles of other
potential routes of exposure such as skin,
upper respiratory tract, and mucus membranes
in development of sensitization and disease
(Weissman and Lewis 2002). In some situa-
tions such as asthma attributed to poor indoor
air quality, causative agents remain unclear,
although Park et al. (2004) has indicated that
semiquantitative indices of exposure to damp-
ness and mold can suffice for measuring the
effect of poor workplace indoor air quality on
respiratory symptoms. Cox-Ganser et al.
(2005) show that occupancy of water-dam-
aged buildings by workers was associated with
onset and exacerbation of respiratory condi-
tions, confirmed by objective medical tests.
Bornehag et al. (2004) also provide a compre-
hensive review on dampness and mite work-
place exposure in buildings and their
associated health effects. Indoor air exposures
and incident asthma are discussed in more
depth by Gilmour et al. (2006), Zeldin et al.
(2006), and the Institute of Medicine (2000,
2004). Depending on the work setting and
causative agent, conflicting data have been
published about the role of co-exposures such
as tobacco smoke (Gilmour et al. (2006).
Finally, as is true for common asthma, impor-
tant questions remain about genetic and other
individual susceptibility factors.
Older age. On a national level the overall
prevalence of self-reported asthma in the
United States increased from 3.2 to 4.6% in
people 65 or more years of age between 1980
and 1996 (Mannino et al. 2002). As the total
number of people older than 60 years
increases [it is predicted to double between
2000 and 2059 (Kalache and Keller 2000)],
the number of elderly people with asthma will
increase. Moreover, asthma is underdiagnosed
and poorly treated in older adults and substan-
tially reduces quality of life (Bellia et al. 2003;
Dow et al. 2001; Enright et al. 1999; Huss
et al. 2001; Parameswaran et al. 1998). The
prevalence of asthma in an older population
sample of four U.S. communities was 4% for
physician-diagnosed asthma and another 4%
for probable asthma (symptoms of asthma
during the previous 12 months but no diagno-
sis or treatment) (Enright et al. 1999). Older
adults report the onset of their asthma rela-
tively equally over all the decades of life
(Enright et al. 1994).
Exposures associated with asthma in older
adults include indoor and outdoor air pollu-
tion, occupational exposures, and active and
passive smoking. Allergen sensitization has
been associated with asthma in older adults
(Litonjua et al. 1997; Weiss et al. 1998).
Older adults have smaller airways compared
with young adults, and this makes bronchial
hyperresponsiveness more likely (Britton et al.
1994; Peat et al. 1992).
The Centers for Disease Control and
Prevention has yet to conduct longitudinal
studies of asthma incidence. Although the
increased prevalence suggests that the incidence
has also risen, based on currently available data,
it is hard to know how much of the asthma
seen in older adults is newly developed disease
and how much is persistence or recurrence or
exacerbation of disease developed earlier in life.
Up to half of older adults with asthma are
current or former smokers (Enright et al.
1999). Smokers with airway hyperreactivity
are more likely to experience faster decline in
forced expiratory volume in 1 sec than smok-
ers without airway hyperreactivity. Cigarette
smoking enhances the production of IgE anti-
bodies, stimulates the production of inflam-
matory markers in the sputum, and causes
hyperinﬂation in older asthmatics (Mitsunobu
et al. 2004). In Sweden, adult-onset asthma
was associated with exposure to molds, envi-
ronmental tobacco smoke (ETS), and the
presence of a wood-burning stove (Thorn
et al. 2001). In Finland, indoor dampness and
mold growth was found to contribute to
adult-onset asthma (Jaakkola et al. 2002).
Asthma in older women living in Northern
California was associated with occupations in
art, decorating, photography, technology,
health professions, food preparation, cleaning,
social work, and service work (Forastiere et al.
1998), as well as with smoking and exposures
to dusts, gas, vapors, fumes, or sensitizers.
Asthma in older women in developing coun-
tries such as India is associated with the use of
biomass fuels for cooking or home heating,
especially when the stove and sleeping quarters
are located in the same room (Mishra 2003).
If the asthma phenotype is more heteroge-
neous in older adults compared with children,
the strategies needed to prevent new-onset
cases, as well as exacerbation of existing asthma,
in this population may be different from those
needed to protect children. To develop effective
strategies, we need studies that speciﬁcally target
older adults.
Lifestyle: Obesity
Obesity is a large and rapidly growing public
health problem both in the United States and
worldwide. From 1976 through 1994, the
prevalence of overweight children and adoles-
cents in the United States almost doubled
(Jackson 2003). Numerous cross-sectional
epidemiologic studies indicate an increased
prevalence of asthma in the obese (Arif et al.
2003a; Chinn 2003; Luder et al. 2004;
Schachter 2003).
Obesity may be particularly important for
severe asthma because a large epidemiologic
survey indicates that > 75% of subjects visiting
emergency departments for asthma are obese
or overweight (Thomson et al. 2003). These
asthmatics had severities of airﬂow obstruction
similar to those of lean subjects visiting emer-
gency departments for asthma and responded
equally well to standard asthma therapy, indi-
cating that asthma in obese individuals does
not simply reﬂect misdiagnosed dyspnea.
It is important that we understand the
mechanistic basis for the relationship between
obesity and asthma, both because the preva-
lence of obesity is extremely high among
inner-city children (Luder et al. 1998), who
have a particularly high prevalence of asthma,
and because obesity is a strong predictor of the
persistence of childhood asthma into adoles-
cence (Guerra et al. 2004). The relationship is
much stronger in females than in males. In a
birth cohort study of 1,000 individuals
(Hancox et al. 2004), raised body mass index
(BMI) was associated with asthma and atopy
in women but not in men. Population attrib-
utable fraction calculations estimated that
28% (95% CI, 7–45) of asthma developing in
women after 9 years of age is due to being
overweight (Hancox et al. 2004).
Longitudinal studies controlling for other
confounding variables, including exercise,
indicate that obesity antedates asthma and that
Susceptibility factors influencing asthma induction
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with increasing obesity (Camargo et al. 1999;
Castro-Rodriguez et al. 2001; Gold et al.
2003; Guerra et al. 2004). Furthermore, mor-
bidly obese asthmatics studied after weight loss
demonstrate decreased severity and symptoms
of asthma (Aaron et al. 2004; Stenius-Aarniala
et al. 2000). It is likely, therefore, that obesity
somehow either causes or exacerbates asthma.
The mechanistic relationship between obe-
sity and asthma has been studied using mouse
models of the disease. Ob/ob mice, which are
genetically deﬁcient in the satiety hormone lep-
tin [leptin; GenBank accession no. U22421,
mouse (Mus musculus); http://www.ncbi.nlm.
gov]; db/db mice, which lack the leptin recep-
tor isoform 1 gene [lepr; GenBank accession
no. AF039443 (mouse); (http://www.ncbi.
nlm.gov)]; and Cpefat mice, which are geneti-
cally deﬁcient in an enzyme involved in cleav-
age of neuropeptides involved in satiety, are all
obese. Each of these mouse strains demon-
strates innate airway hyperresponsiveness that
is not the result of differences in absolute lung
volume or tidal volume. It has been hypothe-
sized that this airway hyperresponsiveness may
be related to chronic low-grade systemic
inﬂammation, a characteristic of both human
and murine obesity (Bullo et al. 2003;
Takahashi et al. 2003).
Compared with lean mice, obese mice also
demonstrate enhanced increases in airway
inﬂammation and airway responsiveness after
exposure to ozone, a common asthma trigger
(Rivera-Sanchez et al. 2003; Shore et al. 2003).
After allergen sensitization and challenge, obese
mice also have increased changes in baseline
pulmonary mechanics, airway responsiveness,
and serum IgE compared with lean mice. The
relationship between obesity and atopy has
been less well studied in humans than the rela-
tionship between obesity and asthma, but there
are some epidemiologic studies indicating that
higher BMI is associated with increased preva-
lence of atopy (Huang et al. 1999; Schachter
et al. 2003).
Increases in serum leptin observed in obe-
sity may contribute to the increased incidence
of asthma in the obese because leptin, a mem-
ber of the IL-6 family of cytokines, has pro-
inﬂammatory effects. Sensitized wild-type mice
challenged with ovalbumin developed increased
serum leptin, consistent with a recent report
that for comparable BMI, leptin is increased in
asthmatic compared with healthy boys (Guler
et al. 2004). Exogenous leptin administration
in sensitized mice increased allergen-induced
increases in airway responsiveness and serum
IgE without any effects on airway inﬂammation
or TH2 cytokine expression (Shore et al. 2005).
The results suggest that leptin has the potential
to exacerbate asthma in the obese.
Other aspects of lifestyle that are not
discussed in depth here include diet and
exercise separate from their relationship to
obesity, breast-feeding, and “healthy” life-
styles. For example, there may be a role for
antioxidants, omega-3 fatty acids, nonreﬁned
carbohydrates, or other nutrients in the pre-
vention of asthma, although to date the evi-
dence is not conclusive.
The “Hygiene Hypothesis”
In the late 1980s, as the results of the air
pollution and respiratory infections studies on
asthma were being assimilated by the scientiﬁc
community, a critical observation was reported
in the literature noting a strong inverse rela-
tionship between household size and hay fever
in a cohort in the United Kingdom (Strachan
1989). Contrary to the prevailing paradigm
that respiratory infection induces asthma,
Strachan postulated that the association of
large household size and less hay fever could be
explained if allergic diseases were prevented by
infection in early childhood, transmitted by
contact with older siblings. This theory was
colloquially termed the “hygiene hypothesis.”
In support of this hypothesis, historical epi-
demiologic evidence suggests that although the
incidence of infectious disease in childhood
decreased, allergic disease emerged as a post-
industrial revolution phenomenon during the
19th century and continued to increase in
prevalence throughout the 20th century
(Strachan 2000). Childhood infectious diseases
were therefore hypothesized to have a protec-
tive effect on the subsequent development of
allergic disease.
In global collaborative research, inter-
national comparisons such as the International
Study of Asthma and Allergies in Childhood
(ISAAC) found a 15-fold variation in preva-
lence of asthma symptoms among countries.
Economically developed countries tended to
have the higher prevalence (with English-
speaking countries having the highest) (ISAAC
Steering Committee 1998). Asthma prevalence
was also lower in preuniﬁcation East Germany
than in West Germany (von Mutius et al.
1994). These epidemiologic data are compati-
ble with the hygiene hypothesis.
Other epidemiologic evidence found to
support the hygiene hypothesis include a higher
prevalence of eczema, skin prick positivity, and
allergen speciﬁc IgE in children brought up in
smaller and more afﬂuent families and in ﬁrst-
born children (Strachan 1989; Wickens et al.
1999). Early exposure to childhood infections
due to daycare attendance at young ages was
also linked with a lower incidence of asthma in
a Tucson, Arizona, cohort (Ball et al. 2000).
More recently, Braunfahrlander et al.
(2002) and von Mutius et al. (2000) showed a
reduced risk of hay fever, asthma, and atopy in
rural-dwelling children from farming families
compared with nonfarming rural families.
These studies have consistently suggested that
protective exposures for asthma and allergies
are present in the stables and barns of farm ani-
mals. Endotoxin, a component of the cell walls
of gram-negative bacteria (which is ubiquitous
in the modern environment but reaches much
higher levels in areas where livestock animals
are housed), has become a main environmental
exposure of interest. Mechanistically, it is
thought that exposure to microbial products,
and endotoxin specifically, stimulates the
young immune system to develop the TH1
response pathways instead of the TH2 path-
ways and thereby protects against the develop-
ment of asthma and allergy. Other supportive
evidence on factors that may program the ini-
tial susceptibility to asthma and allergy include
studies of parasitic infections (Yazdanbakhsh
and Wahyuni 2005), studies on the use of
acetaminophen/paracetamol in pregnancy
(Shaheen et al. 2005), and migrant studies
(Gold and Acevedo-Garcia 2005).
However, the hygiene hypothesis assumes
that once the immune system proﬁle is devel-
oped in the infant or child, there is no turning
back. Yet there is evidence that the immune
system is not “ﬁxed” after the ﬁrst years of life;
that is, “immune deviation” may take place
throughout life, as OA illustrates (Douwes
et al. 2004). For example, Portengen et al.
(2005) report that endotoxin exposure in
adult pig farmers protects against allergic
sensitization.
On the other hand, some risk factors for
asthma do not neatly fit into the hygiene
hypothesis. These include ETS exposure (par-
ticularly if a mother smokes in pregnancy),
respiratory syntactical virus (RSV) infection,
obesity, pesticide exposures (Hoppin et al.
2003), OA (Elliot et al. 2005), air pollution
(McConnell et al. 2002), and living in inner-
city communities, which have high preva-
lences of asthma across the country. King et al.
(2004) present a thorough review of studies of
factors that have been associated with asthma
incidence to date.
Holt et al. (2005) propose that there may
be interactions between airway tissue damage
in early life caused by viral infections and
inhalant allergy in asthma etiology. We pro-
pose a hypothesis that could account for both
the hygiene hypotheses and other risk factors,
that is, synergistic and/or antagonistic interac-
tions between immune function development
or change (at later stages of life) and structural
damage to the lung (via air pollution, ETS,
RSV) occurring at different time points
throughout life.
The challenge for the future is to identify
the factors that confer the protection proposed
by the hygiene hypothesis and to ﬁnd strate-
gies to modify the environment to reduce the
incidence of asthma and TH2 sensitization to
common environmental antigens without
causing harm to susceptible individuals.
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Much of the ongoing asthma research is based
on “high-risk” cohorts that maximize inclusion
of children with a family history of asthma and
recruit primarily children with allergic asthma.
The knowledge gained from these studies,
although important and useful for high-risk
children, does not represent the entire popula-
tion. There seems to be an assumption that the
only good knowledge left to be gained epidemi-
ologically will come from future and existing
cohort studies. Yet, case–control studies and
cross-sectional studies are still quite useful and
much less costly, take much less time, and can
be used for hypothesis generation. The studies
by Braunfahrlander, von Mutius, and col-
leagues, described previously, are a case in
point. An astute observation that farm children
have a lower prevalence of asthma than non-
farm children has spawned an entire field of
research into endotoxin and toll-like receptors.
There is a dearth of research into factors
associated with asthma and allergy remission.
Remission studies can be highly informative
about the natural history of the disease. In one
of the few reports in this area, Sears et al.
(2003), in a population-based (rather than
high-risk) cohort of children, showed that the
later the age of disease onset in childhood, the
less likely the child would relapse later in adult-
hood. It also demonstrated that smoking was
strongly associated with persistent asthma.
Animal models have been developed pri-
marily for the study of allergic sensitization
rather than asthma. Perhaps toxicologists and
immunologists can also broaden their efforts to
improve animal models of asthma develop-
ment. Collaborative research among epidemiol-
ogists, toxicologists, immunologists, allergists,
occupational hygienists, and pulmonologists
will help us reach our goal of developing strate-
gies to prevent asthma in future generations.
Conclusion
There is substantial evidence that genetics,
obesity, and the window of exposure (fetus,
infant, elderly) are major susceptibility factors
in the pathogenesis of asthmatic disease. Future
research on the incidence and induction of
asthma should take susceptibility factors into
account. New research ﬁndings should then be
used to generate public health interventions
aimed at preventing a further rise in asthma
and ultimately to reverse the existing trend.
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